Concepedia

Author

T F Dekoning

W.E. Upjohn Institute for Employment Research

Also Known As

T F DeKoning, T F Dekoning, T. F. DeKoning, T.F. DeKoning, THOMAS F. DEKONING, Thomas F. DeKoning, Thomas F. Dekoning

16

Publications

418

Citations

8

H-Index

27

Concepts

All Affiliations

W.E. Upjohn Institute for Employment Research
TF

About

T F Dekoning is an author at W.E. Upjohn Institute for Employment Research specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

222

2

Natural Sciences

2

2

179

3

Biochemistry

2

2

179

4

Chemical Biology

2

2

179

5

Cell Biology

1

1

11

T F Dekoning

×

7

Publications

396

Citations

7

H-Index

YearCitations

Preliminary toxicity studies with the DNA-binding antibiotic, CC-1065.

J. Patrick McGovren, George L. Clarke, Evelyn A. Pratt,

The Journal of Antibiotics

1984

144

Cytotoxicity and antitumor activity of carzelesin, a prodrug cyclopropylpyrroloindole analogue.

Li H. Li, T F Dekoning, Robert C. Kelly,

PubMed

1992

95

Adozelesin, a selected lead among cyclopropylpyrroloindole analogs of the DNA-binding antibiotic, CC-1065

Li H. Li, Robert C. Kelly, Martha A. Warpehoski,

Investigational New Drugs

1991

84

Structure and activity relationship of several novel CC-1065 analogs

Li H. Li, Tanya L. Wallace, T F Dekoning,

Investigational New Drugs

1987

30

Preclinical antitumor activity of bizelesin in mice.

Charleata A. Carter, William R. Waud, L H Li,

PubMed

1996

22

Combination efficacy with MetMAb and erlotinib in a NSCLC tumor model highlight therapeutic opportunities for c-Met inhibitors in combination with EGFR inhibitors

Merchant Mark, Yanli Su, María del Socorro Camarillo Romero,

Cancer Research

2008

11

Relationship between modulation of natural killer cell activity and antitumor activity of bropirimine when used in combination with various types of chemotherapeutic drugs.

L.H. Li, T F Dekoning, Tanya L. Wallace

PubMed

1987

10

Page 1